Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) and Morgan Stanley Direct Lending Fund (NYSE:MSDL – Get Free Report) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, dividends, valuation and earnings.
Valuation and Earnings
This table compares Crescent Capital BDC and Morgan Stanley Direct Lending Fund”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Crescent Capital BDC | $197.36 million | 2.75 | $73.65 million | $0.98 | 14.98 |
| Morgan Stanley Direct Lending Fund | $416.08 million | 3.67 | $215.56 million | $1.65 | 10.66 |
Insider & Institutional Ownership
49.5% of Crescent Capital BDC shares are owned by institutional investors. 1.1% of Crescent Capital BDC shares are owned by company insiders. Comparatively, 0.2% of Morgan Stanley Direct Lending Fund shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares Crescent Capital BDC and Morgan Stanley Direct Lending Fund’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Crescent Capital BDC | 20.84% | 9.76% | 4.30% |
| Morgan Stanley Direct Lending Fund | 35.92% | 10.21% | 4.70% |
Analyst Recommendations
This is a summary of recent ratings for Crescent Capital BDC and Morgan Stanley Direct Lending Fund, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Crescent Capital BDC | 1 | 1 | 3 | 1 | 2.67 |
| Morgan Stanley Direct Lending Fund | 0 | 5 | 2 | 0 | 2.29 |
Crescent Capital BDC presently has a consensus target price of $16.38, suggesting a potential upside of 11.55%. Morgan Stanley Direct Lending Fund has a consensus target price of $17.75, suggesting a potential upside of 0.94%. Given Crescent Capital BDC’s stronger consensus rating and higher possible upside, analysts plainly believe Crescent Capital BDC is more favorable than Morgan Stanley Direct Lending Fund.
Volatility and Risk
Crescent Capital BDC has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500. Comparatively, Morgan Stanley Direct Lending Fund has a beta of 0.25, meaning that its share price is 75% less volatile than the S&P 500.
Dividends
Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 11.4%. Morgan Stanley Direct Lending Fund pays an annual dividend of $2.00 per share and has a dividend yield of 11.4%. Crescent Capital BDC pays out 171.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Morgan Stanley Direct Lending Fund pays out 121.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has raised its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
About Crescent Capital BDC
Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
About Morgan Stanley Direct Lending Fund
Morgan Stanley Direct Lending Fund is a business development company. It is a non-diversified, externally managed specialty finance company focused on lending to middle-market companies. Morgan Stanley Direct Lending Fund is based in NEW YORK.
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.
